Osaic Holdings
ACXP icon

Osaic Holdings’s Acurx Pharmaceuticals ACXP Stock Holding History

Osaic Holdings’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371 Hold
100
– – ﹤0.01% 7487
2025
Q4 		$249 Sell
100
-7,724
-99% -$37K ﹤0.01% 7550
2025
Q3 		$3.5K Buy
7,824
+7,301
+1,396% +$44K ﹤0.01% 6937
2025
Q2 		$5.33K Buy
523
+44
+9% +$354 ﹤0.01% 6509
2025
Q1 		$3.74K Sell
479
-107
-18% -$1.44K ﹤0.01% 6330
2024
Q4 		$9.5K Sell
586
-125
-18% -$3.76K ﹤0.01% 5838
2024
Q3 		$27K Sell
711
-50
-7% -$2.12K ﹤0.01% 5177
2024
Q2 		$34.2K Sell
761
-2,102
-73% -$92.4K ﹤0.01% 4972
2024
Q1 		$140K Hold
2,863
– – ﹤0.01% 3981
2023
Q4 		$219K Buy
2,863
+1,563
+120% +$118K ﹤0.01% 3847
2023
Q3 		$39K Buy
1,300
+200
+18% +$7.65K ﹤0.01% 5161
2023
Q2 		$58.3K Buy
1,100
+300
+38% +$17.9K ﹤0.01% 4836
2023
Q1 		$55.4K Buy
800
+200
+33% +$14.6K ﹤0.01% 4878
2022
Q4 		$48K Hold
600
– – ﹤0.01% 4960
2022
Q3 		$36K Buy
600
+50
+9% +$3.74K ﹤0.01% 5137
2022
Q2 		$42K Buy
+550
New +$37K ﹤0.01% 5080
2022
Q1 		– Sell
-250
Closed -$22K – 7199
2021
Q4 		$22K Buy
250
+100
+67% +$9.51K ﹤0.01% 5715
2021
Q3 		$15K Buy
+150
New +$15.5K ﹤0.01% 5942

Other funds holding ACXP

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Osaic Holdings's ACXP Position: Q1 2026 in Review

Osaic Holdings held its Acurx Pharmaceuticals (ACXP) position steady in Q1 2026 at 100 shares worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #7487.

Osaic Holdings first reported a position in ACXP in Q3 2021 and has held it in 18 quarters since. The position peaked at $219K in Q4 2023. 21 funds tracked by Wall St. Rank hold ACXP as of Q1 2026.

  • Osaic Holdings held 100 shares of Acurx Pharmaceuticals worth $371 as of Q1 2026.
  • Osaic Holdings left its Acurx Pharmaceuticals share count unchanged in Q1 2026.
  • Acurx Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7487 holding.
  • Osaic Holdings first reported a position in Acurx Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • Osaic Holdings's Acurx Pharmaceuticals position peaked at $219K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.